178 related articles for article (PubMed ID: 10650814)
1. Chemosensitivity test is useful in evaluating the appropriate adjuvant cancer chemotherapy for stage III non-scirrhous and scirrhous gastric cancers.
Abe S; Kubota T; Matsuzaki SW; Otani Y; Watanabe M; Teramoto T; Kumai K; Kitajima M
Anticancer Res; 1999; 19(5C):4581-6. PubMed ID: 10650814
[TBL] [Abstract][Full Text] [Related]
2. Cancer chemotherapy chemosensitivity testing is useful in evaluating the appropriate adjuvant cancer chemotherapy for stages III/IV gastric cancers without peritoneal dissemination.
Kubota T; Egawa T; Otani Y; Furukawa T; Saikawa Y; Yoshida M; Watanabe M; Kumai K; Kitajima M
Anticancer Res; 2003; 23(1B):583-7. PubMed ID: 12680150
[TBL] [Abstract][Full Text] [Related]
3. Role of the MTT chemosensitivity test in the prognosis of gastric cancer patients after postoperative adjuvant chemotherapy.
Nakamura R; Saikawa Y; Kubota T; Kumagai A; Kiyota T; Ohashi M; Yoshida M; Otani Y; Kumai K; Kitajima M
Anticancer Res; 2006; 26(2B):1433-7. PubMed ID: 16619555
[TBL] [Abstract][Full Text] [Related]
4. Individualized adjuvant chemotherapy guided by chemosensitivity test sequential to extended surgery for advanced gastric cancer.
Iwahashi M; Nakamori M; Nakamura M; Noguchi K; Ueda K; Nakatani Y; Ojima T; Ishida K; Naka T; Yamaue H
Anticancer Res; 2005; 25(5):3453-9. PubMed ID: 16101163
[TBL] [Abstract][Full Text] [Related]
5. Single-cell suspension assay with an MTT end point is useful for evaluating the optimal adjuvant chemotherapy for advanced gastric cancer.
Saikawa Y; Kubota T; Furukawa T; Suto A; Watanabe M; Kumai K; Ishibiki K; Kitajima M
Jpn J Cancer Res; 1994 Jul; 85(7):762-5. PubMed ID: 8071118
[TBL] [Abstract][Full Text] [Related]
6. Clinical applications of the histoculture drug response assay.
Furukawa T; Kubota T; Hoffman RM
Clin Cancer Res; 1995 Mar; 1(3):305-11. PubMed ID: 9815986
[TBL] [Abstract][Full Text] [Related]
7. Outcome of surgical treatment for patients with scirrhous carcinoma of the stomach.
Otsuji E; Kuriu Y; Okamoto K; Ochiai T; Ichikawa D; Hagiwara A; Yamagishi H
Am J Surg; 2004 Sep; 188(3):327-32. PubMed ID: 15450843
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of chemosensitivity testing with highly purified tumor cells in 435 patients with gastric carcinoma using an MTT assay.
Noguchi K; Iwahashi M; Tani M; Nakamura M; Nakamori M; Nakatani Y; Ueda K; Ishida K; Naka T; Ojima T; Hotta T; Mizobata S; Yamaue H
Anticancer Res; 2005; 25(2A):931-7. PubMed ID: 15868930
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of sequential high-dose methotrexate and fluorouracil combined with doxorubicin as a neoadjuvant chemotherapy for scirrhous gastric cancer.
Takahashi S; Kinoshita T; Konishi M; Nakagouri T; Inoue K; Ono M; Sugitou M; Ohtsu A; Boku N; Yoshida S
Gastric Cancer; 2001; 4(4):192-7. PubMed ID: 11846062
[TBL] [Abstract][Full Text] [Related]
10. Further evidence for the value of the chemosensitivity test in deciding appropriate chemotherapy for advanced gastric cancer.
Fujita K; Kubota T; Matsuzaki SW; Otani Y; Watanabe M; Teramoto T; Kumai K; Kitajima M
Anticancer Res; 1998; 18(3B):1973-8. PubMed ID: 9677452
[TBL] [Abstract][Full Text] [Related]
11. Clinical usefulness of chemosensitivity test for advanced colorectal cancer.
Kabeshima Y; Kubota T; Watanabe M; Hasegawa H; Furukawa T; Kitajima M
Anticancer Res; 2002; 22(5):3033-7. PubMed ID: 12530038
[TBL] [Abstract][Full Text] [Related]
12. Impact of S-1 plus Cisplatin Neoadjuvant Chemotherapy on Scirrhous Gastric Cancer.
Kunisaki C; Makino H; Kimura J; Takagawa R; Kanazawa A; Ota M; Kosaka T; Ono HA; Akiyama H; Endo I
Oncology; 2015; 88(5):281-8. PubMed ID: 25591954
[TBL] [Abstract][Full Text] [Related]
13. [Chemosensitivity test for gastric cancer by in vitro MTT assay].
Ohyama S; Yonemura Y; Kinoshita K; Ninomiya I; Tugawa K; Kimura H; Miyazaki I; Tanaka M; Endo Y; Sasaki T
Gan To Kagaku Ryoho; 1991 Aug; 18(10):1593-7. PubMed ID: 1908213
[TBL] [Abstract][Full Text] [Related]
14. In vitro chemosensitivity test of human gastric carcinomas using collagen gel matrix.
Ohyama S; Tanaka M; Yonemura Y; Kinoshita K; Miyazaki I; Sasaki T
Jpn J Cancer Res; 1991 May; 82(5):607-12. PubMed ID: 1648053
[TBL] [Abstract][Full Text] [Related]
15. Chemosensitivity testing of fresh human gastric cancer with highly purified tumour cells using the MTT assay.
Yamaue H; Tanimura H; Noguchi K; Hotta T; Tani M; Tsunoda T; Iwahashi M; Tamai M; Iwakura S
Br J Cancer; 1992 Nov; 66(5):794-9. PubMed ID: 1419622
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma.
Koo DH; Lee JL; Kim TW; Chang HM; Ryu MH; Yook JH; Oh ST; Kim BS; Lee JS; Kang YK
Eur J Surg Oncol; 2007 Sep; 33(7):843-8. PubMed ID: 17207959
[TBL] [Abstract][Full Text] [Related]
17. Synergistic antitumor effects of FGFR2 inhibitor with 5-fluorouracil on scirrhous gastric carcinoma.
Yashiro M; Shinto O; Nakamura K; Tendo M; Matsuoka T; Matsuzaki T; Kaizaki R; Miwa A; Hirakawa K
Int J Cancer; 2010 Feb; 126(4):1004-16. PubMed ID: 19621385
[TBL] [Abstract][Full Text] [Related]
18. Recent results of therapy for scirrhous gastric cancer.
Ikeguchi M; Miyake T; Matsunaga T; Yamamoto M; Fukumoto Y; Yamada Y; Fukuda K; Saito H; Tatebe S; Tsujitani S
Surg Today; 2009; 39(4):290-4. PubMed ID: 19319634
[TBL] [Abstract][Full Text] [Related]
19. [Treatment strategy for the type IV gastric cancer--from the standpoint of the surgery].
Nashimoto A; Yabusaki H; Nakagawa S
Gan To Kagaku Ryoho; 2007 Jul; 34(7):983-7. PubMed ID: 17637531
[TBL] [Abstract][Full Text] [Related]
20. [A case report of scirrhous gastric carcinoma diagnosed by staging laparoscopy].
Kawabata R; Imamura H; Kishimoto T; Munakata S; Yamamoto T; Takemoto H; Fukunaga M; Ohzato H; Furukawa H
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2137-9. PubMed ID: 22202308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
